These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1311461)

  • 1. [A case from practice (236). 1. Fulminant hepatitis B. 2. Carrier of HCV antibodies. 3. Intravenous drug abuse].
    Longauer M
    Schweiz Rundsch Med Prax; 1992 Feb; 81(8):234-5. PubMed ID: 1311461
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological status for HBV and HCV infection in anti-HIV seropositive and seronegative intravenous drug abusers.
    De Mercato R; Oriani G; Guarnaccia D; Romano A; Ciampi R; Cantiello JP; Di Pietro M; Celentano U; Riganti C; Romano C
    Boll Soc Ital Biol Sper; 1991 Jan; 67(1):103-8. PubMed ID: 1909531
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of antibody to hepatitis C virus in chronic HBsAg carriers.
    Rodríguez M; Navascues CA; Martínez A; Suárez A; Riestra S; Sala P; González M; Rodrigo L
    Arch Virol Suppl; 1992; 4():327-8. PubMed ID: 1333329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute delta hepatitis in Greek parenteral drug abusers.
    Tassopoulos NC; Koutelou MG; Papatheodoridis GV; Kalantzakis YS; Hatzakis AE
    Prog Clin Biol Res; 1993; 382():221-7. PubMed ID: 8502685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of antibody to hepatitis C virus in 177 drug addicts].
    Ye S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):45-8. PubMed ID: 8389248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of HBV and HCV markers among intravenous drug abusers and subjects affected by chronic active hepatitis.
    De Mercato R; Ciampi R; Romano A; Guarnaccia D; Siciliano V; Cantiello JP; Rippa O; Celentano U; Selva V; Romano C
    Boll Soc Ital Biol Sper; 1990 Sep; 66(9):841-7. PubMed ID: 2127365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibody prevalence for hepatitis C and other parenterally transmissible viral diseases in i. v. drug dependent patients].
    Neuwald C; Pont J; Tomasits J; Bauer K
    Acta Med Austriaca; 1992; 19(2):47-8. PubMed ID: 1324551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological markers of selected viral infections transmitted by parenteral route in drug addicts].
    Halota W; Opoka J; Trzciński J; Dorau M; Topczewska E; Giziński W; Bulik F
    Przegl Epidemiol; 1991; 45(4):347-9. PubMed ID: 1668703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis C antibodies in acute Non-A, Non-B hepatitis].
    Zellweger U; Havelka J; Zala G; Altorfer J; Joller-Jemelka HI; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1991 May; 121(20):761-3. PubMed ID: 1711714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and C infection among drug abusers in Nepal.
    Shrestha SM; Shrestha DM; Gafney TE; Maharjan KG; Tsuda F; Okamoto H
    Trop Gastroenterol; 1996; 17(4):212-3. PubMed ID: 9094859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of HDV infection in Sardinia, an island with a high endemicity for HBV. A multicentre study.
    Farci P; Orgiana G; Coiana A; Peddis G; Mandas A; Lai ME; Giulia Farci AM; Chessa L; Balestrieri A; Arnone M
    Prog Clin Biol Res; 1991; 364():41-50. PubMed ID: 2020717
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug addiction and hepatitis C: does a correlation exist between the laboratory and clinical pictures?].
    Marioni CF; Rapisarda L; Butelli S
    Recenti Prog Med; 1992 Dec; 83(12):690-1. PubMed ID: 1337387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral infections in a sample of intravenous drug abuser prisoners.
    Lanciani P; Taborchi M; Ceralli F
    Panminerva Med; 1992; 34(4):185-6. PubMed ID: 1338122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis C virus in intravenous drug addicts.
    Verdier D; Boissonnas A; Pouliquen-Nicol A; Christoforov B
    Eur J Med; 1993 Apr; 2(4):253. PubMed ID: 7505162
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of antibodies to hepatitis C virus in patients with chronic liver disease.
    Burt MJ; Hann DJ; Schousboe MI; Wilkinson ID; Chapman BA
    N Z Med J; 1992 May; 105(934):195-6. PubMed ID: 1320757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C viral infection and the consumption of intravenous drugs].
    Payeras Cifre A; Socías Moyá M; Forteza-Rei Borralleras J; Besalduch Vidal J
    Rev Sanid Hig Publica (Madr); 1992; 66(3-4):233-7. PubMed ID: 1366219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
    Wang SP; Ding H; Zhao OK
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
    Matheï C; Buntinx F; Van Damme P
    J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.